Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of nonalcoholic steatohepatitis
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, et al.
Cellular and Molecular Life Sciences (2016) Vol. 73, Iss. 10, pp. 1969-1987
Open Access | Times Cited: 196

Showing 1-25 of 196 citing articles:

Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva, David A. Brenner
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 151-166
Closed Access | Times Cited: 1284
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Marcelo A. Mori, Raissa G. Ludwig, Rubén García-Martín, et al.
Cell Metabolism (2019) Vol. 30, Iss. 4, pp. 656-673
Open Access | Times Cited: 719
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
C. Ronald Kahn, Guoxiao Wang, Kevin Y. Lee
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 3990-4000
Open Access | Times Cited: 505
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Daniela Maria Tănase, Evelina Maria Gosav, Claudia Florida Costea, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 410
Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation
Vivek Singh, Saba Ubaid
Inflammation (2020) Vol. 43, Iss. 5, pp. 1589-1598
Closed Access | Times Cited: 315
Emerging roles of SIRT1 in fatty liver diseases
Ren‐Bo Ding, Jiaolin Bao, Chu‐Xia Deng
International Journal of Biological Sciences (2017) Vol. 13, Iss. 7, pp. 852-867
Open Access | Times Cited: 299
Hesperetin ameliorates hepatic oxidative stress and inflammationviathe PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD
Jingda Li, Tianqi Wang, Panpan Liu, et al.
Food & Function (2021) Vol. 12, Iss. 9, pp. 3898-3918
Closed Access | Times Cited: 276
Angiogenesis in chronic liver disease and its complications
Stéphanie Coulon, Femke Heindryckx, Anja Geerts, et al.
Liver International (2010) Vol. 31, Iss. 2, pp. 146-162
Open Access | Times Cited: 255
PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics
Huazhong Ying, Qin Chen, Wenyou Zhang, et al.
Molecular Medicine Reports (2017) Vol. 16, Iss. 6, pp. 7879-7889
Open Access | Times Cited: 189
MAIT cells: new guardians of the liver
Ayako Kurioka, L J Walker, Paul Klenerman, et al.
Clinical & Translational Immunology (2016) Vol. 5, Iss. 8
Open Access | Times Cited: 173
ONOO–-activatable and LD-traced NIR fluorescent probe for mechanism study and early diagnosis of NAFLD and diabetes induced liver injury
Nannan Wang, Xiaoyan Lu, Jiamin Wang, et al.
Sensors and Actuators B Chemical (2024) Vol. 412, pp. 135806-135806
Closed Access | Times Cited: 32
Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus
Mengmeng Hu, Jingyu Yang, Beibei Gao, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 2
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1778-1778
Open Access | Times Cited: 2
Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats
Masatsugu Ohara, Shunsuke Ohnishi, Hidetaka Hosono, et al.
Stem Cells International (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 128
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Fabiana de Faria Ghetti, Daiane Gonçalves de Oliveira, Juliano Machado de Oliveira, et al.
European Journal of Nutrition (2017) Vol. 57, Iss. 3, pp. 861-876
Closed Access | Times Cited: 116
Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease
Jin Wang, Wanping He, Ping-Ju Tsai, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 114
Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells
Fatjon Leti, Christophe Legendre, Christopher D. Still, et al.
Translational research (2017) Vol. 190, pp. 25-39.e21
Open Access | Times Cited: 108
Nutrition, inflammation and liver-spleen axis
Luigi Barrea, Carolina Di Somma, Giovanna Muscogiuri, et al.
Critical Reviews in Food Science and Nutrition (2017) Vol. 58, Iss. 18, pp. 3141-3158
Closed Access | Times Cited: 106
p62/SQSTM1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
Koji Taniguchi, Shinichiro Yamachika, Feng He, et al.
FEBS Letters (2016) Vol. 590, Iss. 15, pp. 2375-2397
Open Access | Times Cited: 105
A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway
Lichen Bao, Jun Yin, Wen Gao, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 16, pp. 3379-3393
Open Access | Times Cited: 84
Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
Tian Lan, Shuo Jiang, Jing Zhang, et al.
Hepatology (2021) Vol. 76, Iss. 1, pp. 155-171
Open Access | Times Cited: 63
MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Zhiqiang Fang, Guo‐Rui Dou, Lin Wang
International Journal of Biological Sciences (2021) Vol. 17, Iss. 7, pp. 1851-1863
Open Access | Times Cited: 58
Notch‐triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase
Zhiqiang Fang, Bai Ruan, Jingjing Liu, et al.
Hepatology (2022) Vol. 76, Iss. 3, pp. 742-758
Closed Access | Times Cited: 45
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Leke Wiering, Pallavi Subramanian, Linda Hammerich
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1277-1292
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top